Health Canada authorizes a new weapon against multiple myeloma

For example,

Health canada authorizes new weapon:

Bélantamab Mafodotin for injection. Nevertheless, which is known by its trade name in Blenrep, does not heal the disease, but it stopped the progression for a duration of up to 36.6 months during clinical trials.

“For multiple myeloma. Meanwhile, this is the first member of this family called antibodies combined with toxins,” said Doctor Richard Leblanc, who is in particular holder of the Myelome Canada Chair on the Multiple Myelome of the University of Montreal at the Maisonneuve-Rosemont hospital.

“It is not only an antibody that has an immune effect against cancer, in addition it (…) releases a toxin in the tumor cell, which harms the survival of the cancer cell.”

More specifically. Furthermore, Health Canada has approved the use of Blenrep “in combination with BORTEZOMIB and Dexamethasone, or in combination with pomalidomide and dexamethasone, for the treatment of adult patients with health canada authorizes new weapon a recurrent or refractory multiple myeloma having received at least one previous treatment line, including lenalidomide in the second association” by press release.

To see too | Significant increase in cases of aggressive skin cancer in Estrie

Blenrep is a form of immunotherapy. In addition, The molecule developed by the pharmaceutical giant GSK therefore stimulates the patient’s immune system to attack. Nevertheless, destroy the disease, but it also releases toxic agent inside cancer cells.

It also has the advantage of not attacking healthy cells.

“It is an antibody that was a little suitable in the laboratory to be combined with a toxin. Meanwhile, ” said Doctor Blais. And so when it is injected. this antibody will set itself to the place where it has been programmed to fix itself and it will release toxin in the cell to make life difficult to the cell. ”

Doctors health canada authorizes new weapon today have several drugs to fight multiple myeloma. he added, but it is still not possible to cure the disease.

The majority of patients will respond favorably to the first line of treatment. giving them a few years of quality life, but therapy will eventually lose its effectiveness sooner or later and it will be necessary to find something else, said Doctor Leblanc.

“This is where it is important to have a second-line treatment. ” he said. But the same scenario will repeat itself in the second line. and we will have to have a third line and a fourth line. So. in the context of an illness that we do not heal, having multiple treatment options with different action mechanisms is something very desirable. ”

Benlep’s approval “is really an important step because we give people for quality,” he concluded.

More than four health canada authorizes new weapon thousand Canadians received a diagnosis of multiple myeloma in 2024. He is among the most widespread blood cancers in the world. The disease causes anemia, intense fatigue, bone pain, spontaneous fractures, frequent infections and sometimes reaches the kidneys.

!(function(f, b, e, v, n, t, s) { if (f.fbq) return; n = f.fbq = function() { n.callMethod ? n.callMethod.apply(n, arguments) : n.queue.push(arguments); }; if (!f._fbq) f._fbq = n; n.push = n; n.loaded = !0; n.version = “2.0”; n.queue = []; t = b.createElement(e); t.async = !0; t.src = v; s = b.getElementsByTagName(e)[0]; s.parentNode.insertBefore(t, s); })( window, document, “script”, “https://connect.facebook.net/en_US/fbevents.js” ); fbq(“init”, “198053572435923”); fbq(“track”, “PageView”);

Health canada authorizes new weapon

Further reading: Quebec City withdrew to a pro-Trump American singer the license for a concert scheduled for FridayHockey Canada completes its coach staffWhat you need to know this Thursday | Haitian migrants in the United States, Trump health and Pasta StefanoA new stamp draws attention to the history of civil internment in CanadaDrug traffickers target evacuated in Winnipeg.

Comments (0)
Add Comment